Pharma & Healthcare
Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Research Report 2026
- Feb 03, 26
- ID: 702570
- Pages: 112
- Figures: 108
- Views: 11
This report delivers a comprehensive overview of the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Granulocyte Macrophage Colony Stimulating Factor (GM-CSF). The Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Partner Therapeutics
Nobelpharma
Changchun GeneScience Pharmaceutical
North China Pharmaceutical
Amoytop Biotech
Hainan Unipul Pharmaceutical
Harbin Pharmaceutical Group
Guangzhou Baiyunshan Pharmaceutical
Segment by Type
Injection
Inhalation
Other
by Application
Infectious Disease Treatment
Cancer Treatment Support
Proteinosis Autoimmune Pulmonary Alveolar
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Partner Therapeutics
Nobelpharma
Changchun GeneScience Pharmaceutical
North China Pharmaceutical
Amoytop Biotech
Hainan Unipul Pharmaceutical
Harbin Pharmaceutical Group
Guangzhou Baiyunshan Pharmaceutical
Segment by Type
Injection
Inhalation
Other
by Application
Infectious Disease Treatment
Cancer Treatment Support
Proteinosis Autoimmune Pulmonary Alveolar
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Overview
1.1 Product Definition
1.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Type
1.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Type: 2025 vs 2032
1.2.2 Injection
1.2.3 Inhalation
1.2.4 Other
1.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Application
1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Application: 2025 vs 2032
1.3.2 Infectious Disease Treatment
1.3.3 Cancer Treatment Support
1.3.4 Proteinosis Autoimmune Pulmonary Alveolar
1.3.5 Other
1.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Estimates and Forecasts
1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue 2021–2032
1.4.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales 2021–2032
1.4.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Competition by Manufacturers
2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Product Types and Applications
2.7 Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Date of Entry into the Industry
2.8 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Competitive Situation and Trends
2.8.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Players Market Share by Revenue
2.8.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Scenario by Region
3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2021–2032
3.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2021–2026
3.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2027–2032
3.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2021–2032
3.3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2021–2026
3.3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2027–2032
3.4 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.4.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021–2032)
3.4.3 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.5.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021–2032)
3.5.3 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Region
3.6.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2021–2032)
3.6.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.7.1 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021–2032)
3.7.3 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.8.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021–2032)
4.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021–2026)
4.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027–2032)
4.1.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021–2032)
4.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021–2032)
4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021–2026)
4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2027–2032)
4.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021–2032)
4.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021–2032)
5.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021–2026)
5.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027–2032)
5.1.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021–2032)
5.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021–2032)
5.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021–2026)
5.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2027–2032)
5.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021–2032)
5.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Partner Therapeutics
6.1.1 Partner Therapeutics Company Information
6.1.2 Partner Therapeutics Description and Business Overview
6.1.3 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.1.5 Partner Therapeutics Recent Developments/Updates
6.2 Nobelpharma
6.2.1 Nobelpharma Company Information
6.2.2 Nobelpharma Description and Business Overview
6.2.3 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.2.5 Nobelpharma Recent Developments/Updates
6.3 Changchun GeneScience Pharmaceutical
6.3.1 Changchun GeneScience Pharmaceutical Company Information
6.3.2 Changchun GeneScience Pharmaceutical Description and Business Overview
6.3.3 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.3.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates
6.4 North China Pharmaceutical
6.4.1 North China Pharmaceutical Company Information
6.4.2 North China Pharmaceutical Description and Business Overview
6.4.3 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.4.5 North China Pharmaceutical Recent Developments/Updates
6.5 Amoytop Biotech
6.5.1 Amoytop Biotech Company Information
6.5.2 Amoytop Biotech Description and Business Overview
6.5.3 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.5.5 Amoytop Biotech Recent Developments/Updates
6.6 Hainan Unipul Pharmaceutical
6.6.1 Hainan Unipul Pharmaceutical Company Information
6.6.2 Hainan Unipul Pharmaceutical Description and Business Overview
6.6.3 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.6.5 Hainan Unipul Pharmaceutical Recent Developments/Updates
6.7 Harbin Pharmaceutical Group
6.7.1 Harbin Pharmaceutical Group Company Information
6.7.2 Harbin Pharmaceutical Group Description and Business Overview
6.7.3 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.8 Guangzhou Baiyunshan Pharmaceutical
6.8.1 Guangzhou Baiyunshan Pharmaceutical Company Information
6.8.2 Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
6.8.3 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.8.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Chain Analysis
7.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Production Mode & Process Analysis
7.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Marketing
7.4.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Channels
7.4.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors
7.5 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customer Analysis
8 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Dynamics
8.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Trends
8.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Drivers
8.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Challenges
8.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Type
1.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Type: 2025 vs 2032
1.2.2 Injection
1.2.3 Inhalation
1.2.4 Other
1.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Application
1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Application: 2025 vs 2032
1.3.2 Infectious Disease Treatment
1.3.3 Cancer Treatment Support
1.3.4 Proteinosis Autoimmune Pulmonary Alveolar
1.3.5 Other
1.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Estimates and Forecasts
1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue 2021–2032
1.4.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales 2021–2032
1.4.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Competition by Manufacturers
2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Product Types and Applications
2.7 Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Date of Entry into the Industry
2.8 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Competitive Situation and Trends
2.8.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Players Market Share by Revenue
2.8.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Scenario by Region
3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2021–2032
3.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2021–2026
3.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2027–2032
3.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2021–2032
3.3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2021–2026
3.3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2027–2032
3.4 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.4.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021–2032)
3.4.3 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.5.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021–2032)
3.5.3 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Region
3.6.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2021–2032)
3.6.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.7.1 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021–2032)
3.7.3 Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Facts & Figures by Country
3.8.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021–2032)
4.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021–2026)
4.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027–2032)
4.1.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021–2032)
4.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021–2032)
4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021–2026)
4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2027–2032)
4.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021–2032)
4.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021–2032)
5.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021–2026)
5.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027–2032)
5.1.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021–2032)
5.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021–2032)
5.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021–2026)
5.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2027–2032)
5.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021–2032)
5.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Partner Therapeutics
6.1.1 Partner Therapeutics Company Information
6.1.2 Partner Therapeutics Description and Business Overview
6.1.3 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.1.5 Partner Therapeutics Recent Developments/Updates
6.2 Nobelpharma
6.2.1 Nobelpharma Company Information
6.2.2 Nobelpharma Description and Business Overview
6.2.3 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.2.5 Nobelpharma Recent Developments/Updates
6.3 Changchun GeneScience Pharmaceutical
6.3.1 Changchun GeneScience Pharmaceutical Company Information
6.3.2 Changchun GeneScience Pharmaceutical Description and Business Overview
6.3.3 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.3.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates
6.4 North China Pharmaceutical
6.4.1 North China Pharmaceutical Company Information
6.4.2 North China Pharmaceutical Description and Business Overview
6.4.3 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.4.5 North China Pharmaceutical Recent Developments/Updates
6.5 Amoytop Biotech
6.5.1 Amoytop Biotech Company Information
6.5.2 Amoytop Biotech Description and Business Overview
6.5.3 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.5.5 Amoytop Biotech Recent Developments/Updates
6.6 Hainan Unipul Pharmaceutical
6.6.1 Hainan Unipul Pharmaceutical Company Information
6.6.2 Hainan Unipul Pharmaceutical Description and Business Overview
6.6.3 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.6.5 Hainan Unipul Pharmaceutical Recent Developments/Updates
6.7 Harbin Pharmaceutical Group
6.7.1 Harbin Pharmaceutical Group Company Information
6.7.2 Harbin Pharmaceutical Group Description and Business Overview
6.7.3 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.8 Guangzhou Baiyunshan Pharmaceutical
6.8.1 Guangzhou Baiyunshan Pharmaceutical Company Information
6.8.2 Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
6.8.3 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
6.8.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Chain Analysis
7.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Production Mode & Process Analysis
7.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Marketing
7.4.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Channels
7.4.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors
7.5 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customer Analysis
8 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Dynamics
8.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Trends
8.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Drivers
8.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Challenges
8.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Competitive Situation by Manufacturers in 2025
Table 4. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Product Types and Applications
Table 12. Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (K Units), 2021–2026
Table 18. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2021–2026)
Table 19. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (K Units), 2027–2032
Table 20. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2027–2032)
Table 21. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (US$ Million), 2021–2026
Table 22. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2021–2026)
Table 23. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (US$ Million), 2027–2032
Table 24. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2027–2032)
Table 25. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2021–2026
Table 27. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2027–2032
Table 28. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2021–2026
Table 29. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2021–2026
Table 32. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2027–2032
Table 33. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2021–2026
Table 42. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2027–2032
Table 43. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2027–2032
Table 50. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Type (2021–2026)
Table 51. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Type (2027–2032)
Table 52. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021–2026)
Table 53. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2027–2032)
Table 54. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021–2026)
Table 57. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2027–2032)
Table 58. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Type (2021–2026)
Table 59. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Type (2027–2032)
Table 60. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Application (2021–2026)
Table 61. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Application (2027–2032)
Table 62. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021–2026)
Table 63. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2027–2032)
Table 64. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021–2026)
Table 67. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2027–2032)
Table 68. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Application (2021–2026)
Table 69. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Application (2027–2032)
Table 70. Partner Therapeutics Company Information
Table 71. Partner Therapeutics Description and Business Overview
Table 72. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 74. Partner Therapeutics Recent Developments/Updates
Table 75. Nobelpharma Company Information
Table 76. Nobelpharma Description and Business Overview
Table 77. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 79. Nobelpharma Recent Developments/Updates
Table 80. Changchun GeneScience Pharmaceutical Company Information
Table 81. Changchun GeneScience Pharmaceutical Description and Business Overview
Table 82. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 84. Changchun GeneScience Pharmaceutical Recent Developments/Updates
Table 85. North China Pharmaceutical Company Information
Table 86. North China Pharmaceutical Description and Business Overview
Table 87. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 89. North China Pharmaceutical Recent Developments/Updates
Table 90. Amoytop Biotech Company Information
Table 91. Amoytop Biotech Description and Business Overview
Table 92. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 94. Amoytop Biotech Recent Developments/Updates
Table 95. Hainan Unipul Pharmaceutical Company Information
Table 96. Hainan Unipul Pharmaceutical Description and Business Overview
Table 97. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 99. Hainan Unipul Pharmaceutical Recent Developments/Updates
Table 100. Harbin Pharmaceutical Group Company Information
Table 101. Harbin Pharmaceutical Group Description and Business Overview
Table 102. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 104. Harbin Pharmaceutical Group Recent Developments/Updates
Table 105. Guangzhou Baiyunshan Pharmaceutical Company Information
Table 106. Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
Table 107. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 109. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors List
Table 113. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers List
Table 114. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Trends
Table 115. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Drivers
Table 116. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Challenges
Table 117. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
Figure 2. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Type: 2025 & 2032
Figure 4. Injection Product Picture
Figure 5. Inhalation Product Picture
Figure 6. Other Product Picture
Figure 7. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Application: 2025 & 2032
Figure 9. Infectious Disease Treatment
Figure 10. Cancer Treatment Support
Figure 11. Proteinosis Autoimmune Pulmonary Alveolar
Figure 12. Other
Figure 13. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size (US$ Million), 2021–2032
Figure 15. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), 2021–2032
Figure 16. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price (US$/Unit), 2021–2032
Figure 17. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Report Years Considered
Figure 18. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Manufacturers in 2025
Figure 19. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Players: Market Share by Revenue in Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in 2025
Figure 21. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021–2032)
Figure 24. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021–2032)
Figure 25. United States Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021–2032)
Figure 28. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021–2032)
Figure 29. Germany Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2021–2032)
Figure 36. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021–2032)
Figure 44. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Type (2021–2032)
Figure 55. Global Revenue Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Type (2021–2032)
Figure 56. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Application (2021–2032)
Figure 58. Global Revenue Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Application (2021–2032)
Figure 59. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Application (2021–2032)
Figure 60. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Competitive Situation by Manufacturers in 2025
Table 4. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Product Types and Applications
Table 12. Global Key Manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (K Units), 2021–2026
Table 18. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2021–2026)
Table 19. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (K Units), 2027–2032
Table 20. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2027–2032)
Table 21. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (US$ Million), 2021–2026
Table 22. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2021–2026)
Table 23. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (US$ Million), 2027–2032
Table 24. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2027–2032)
Table 25. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2021–2026
Table 27. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2027–2032
Table 28. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2021–2026
Table 29. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2021–2026
Table 32. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2027–2032
Table 33. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2021–2026
Table 42. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2027–2032
Table 43. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Country (US$ Million), 2027–2032
Table 50. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Type (2021–2026)
Table 51. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Type (2027–2032)
Table 52. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021–2026)
Table 53. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2027–2032)
Table 54. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021–2026)
Table 57. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2027–2032)
Table 58. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Type (2021–2026)
Table 59. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Type (2027–2032)
Table 60. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Application (2021–2026)
Table 61. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units) by Application (2027–2032)
Table 62. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021–2026)
Table 63. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2027–2032)
Table 64. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021–2026)
Table 67. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2027–2032)
Table 68. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Application (2021–2026)
Table 69. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Application (2027–2032)
Table 70. Partner Therapeutics Company Information
Table 71. Partner Therapeutics Description and Business Overview
Table 72. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 74. Partner Therapeutics Recent Developments/Updates
Table 75. Nobelpharma Company Information
Table 76. Nobelpharma Description and Business Overview
Table 77. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 79. Nobelpharma Recent Developments/Updates
Table 80. Changchun GeneScience Pharmaceutical Company Information
Table 81. Changchun GeneScience Pharmaceutical Description and Business Overview
Table 82. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 84. Changchun GeneScience Pharmaceutical Recent Developments/Updates
Table 85. North China Pharmaceutical Company Information
Table 86. North China Pharmaceutical Description and Business Overview
Table 87. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 89. North China Pharmaceutical Recent Developments/Updates
Table 90. Amoytop Biotech Company Information
Table 91. Amoytop Biotech Description and Business Overview
Table 92. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 94. Amoytop Biotech Recent Developments/Updates
Table 95. Hainan Unipul Pharmaceutical Company Information
Table 96. Hainan Unipul Pharmaceutical Description and Business Overview
Table 97. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 99. Hainan Unipul Pharmaceutical Recent Developments/Updates
Table 100. Harbin Pharmaceutical Group Company Information
Table 101. Harbin Pharmaceutical Group Description and Business Overview
Table 102. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 104. Harbin Pharmaceutical Group Recent Developments/Updates
Table 105. Guangzhou Baiyunshan Pharmaceutical Company Information
Table 106. Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
Table 107. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product
Table 109. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors List
Table 113. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers List
Table 114. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Trends
Table 115. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Drivers
Table 116. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Challenges
Table 117. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
Figure 2. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Type: 2025 & 2032
Figure 4. Injection Product Picture
Figure 5. Inhalation Product Picture
Figure 6. Other Product Picture
Figure 7. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Application: 2025 & 2032
Figure 9. Infectious Disease Treatment
Figure 10. Cancer Treatment Support
Figure 11. Proteinosis Autoimmune Pulmonary Alveolar
Figure 12. Other
Figure 13. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size (US$ Million), 2021–2032
Figure 15. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), 2021–2032
Figure 16. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price (US$/Unit), 2021–2032
Figure 17. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Report Years Considered
Figure 18. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Manufacturers in 2025
Figure 19. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Players: Market Share by Revenue in Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in 2025
Figure 21. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021–2032)
Figure 24. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021–2032)
Figure 25. United States Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021–2032)
Figure 28. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021–2032)
Figure 29. Germany Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2021–2032)
Figure 36. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021–2032)
Figure 44. Latin America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Type (2021–2032)
Figure 55. Global Revenue Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Type (2021–2032)
Figure 56. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Application (2021–2032)
Figure 58. Global Revenue Market Share of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Application (2021–2032)
Figure 59. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price (US$/Unit) by Application (2021–2032)
Figure 60. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232